Difference between revisions of "Lorcan"
Jump to navigation
Jump to search
imported>Lorcan |
imported>Lorcan |
||
| Line 121: | Line 121: | ||
| rowspan = "5" | | | rowspan = "5" | | ||
| class = "CTData" | {{:{{PAGENAME}}/Snapshots}}<!-- Do not delete the ':' (colon)! --> | | class = "CTData" | {{:{{PAGENAME}}/Snapshots}}<!-- Do not delete the ':' (colon)! --> | ||
| + | [[Image:Lorcan 2.jpg|center|390px]] | ||
|- | |- | ||
| class = "CTData2 CTHeader" | <span id="I-Hooks">Contacts</span> | | class = "CTData2 CTHeader" | <span id="I-Hooks">Contacts</span> | ||
Revision as of 11:04, 23 September 2018
 |
||
| Navigation: Information, Snapshots, Contacts, Quotes | ||
| Information | Snapshots | |
|
Background: Originally from Boston, Corbin is a rising executive in Magadon Pharmaceuticals (and Pentex). Formerly of the Magadon Special Projects Division, he had a successful career seeking out and developing promising intellectual properties for the Division globally. Several of the compounds, drugs and other substances that he coopted were refined into highly profitable pharmaceuticals. Given his skill at such, he was given the helm of a company venture capital fund, Magadon Ventures, Inc. |
Lorcan/Snapshots
 | |
| Contacts | Quotes | |
| Lorcan/Hooks | Lorcan/Quotes |
RP Logs
No pages meet these criteria.
